IPO registrations (S-1, F-1) · Registrants
INOVIO PHARMACEUTICALS, INC.
- SEC CIK
- 1055726 · filings on EDGAR ↗
- Name on the registration
- GENETRONICS BIOMEDICAL LTD
- Former names
- INOVIO BIOMEDICAL CORP (2005–2010); GENETRONICS BIOMEDICAL CORP (2001–2005); GENETRONICS BIOMEDICAL LTD (1999–2001)
- Registration
- Form S-1, first filed 1999-10-05; 1 initial registration, 0 amendments
- Outcome
- No final prospectus, effectiveness notice or withdrawal within two years of the registration
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, Plymouth Meeting, PA 19462
- EIN
- 33-0969592
- Ticker
- INO (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- INOVIO PHARMACEUTICALS, INC. on the corporate pages
Offering terms
- Shares offered
- 4,142,611 (all by selling holders)
- Listing
- NYSE American under the symbol GEB
- Lead underwriters
- uncollectible accounts of (19,685 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Inovio Pharmaceuticals, Inc. Fuzzy (name and state)
- Business registration: Inovio Pharmaceuticals, Inc. Fuzzy (name and state)
- Business registration: INOVIO PHARMACEUTICALS, INC Fuzzy (name and state)
- Business registration: INOVIO PHARMACEUTICALS, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: INOVIO EXACT (EIN (EXACT))
- Form D issuer: INOVIO PHARMACEUTICALS, INC. EXACT (CIK (EXACT))
- Lobbying client: INOVIO PHARMACEUTICALS Fuzzy (name and state)
- Lobbying client: INOVIO PHARMACEUTICALS Fuzzy (name and state)
- Lobbying client: INOVIO PHARMACEUTICALS, INC. Fuzzy (name and state)
- Lobbying client: INOVIO PHARMACEUTICALS, INC. Fuzzy (name and state)
- Lobbying registrant: INOVIO PHARMACEUTICALS, INC. Fuzzy (name and state)
- SEC filer: INOVIO BIOMEDICAL CORP EXACT (CIK (EXACT))
- Person page: David B Weiner Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 1
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1999-10-05 | S-1 | S-1 (registration) | GENETRONICS BIOMEDICAL LTD | 0000936392-99-001165 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1999-10-05 | S-1 | registration statement | $0.84 | 4,142,611 | $3,479,793 | NYSE American GEB | 1 | from the submission text; price line, shares headline, proceeds computed, underwriting table 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| DHILLON AVTAR S | Director; Director,Officer | Executive Chairman; President & CEO; President & Chairman | 19 | 2006–2018 | |
| GOODENEW ROBERT S | Officer | V.P. Corporate Development | 3 | 2006 | |
| KIES PETER | Officer | CFO | 53 | 2006–2026 | |
| McHugh George F. III | Officer | Vice President, Operations | 1 | 2006 | |
| RABUSSAY DIETMAR P | Officer | V.P. Research & Development | 2 | 2006–2007 | |
| Bandali Riaz Amirali | Director | 3 | 2006–2008 | ||
| BENITO SIMON X | Director | 37 | 2006–2026 | ||
| ESMAIL TAZDIN | Director | 3 | 2006–2008 | ||
| HEPPELL JAMES L | Director | 4 | 2006–2008 | ||
| THEEUWES FELIX | Director | 1 | 2006 | ||
| Rieder Robert William | Director | 3 | 2007–2008 | ||
| Fons Michael | Officer | VP, Corporate Development | 5 | 2007–2009 | |
| DHILLON PUNIT | Officer | VP, Finance & Operations | 5 | 2008–2009 | |
| RIETIKER STEPHEN | Director | 3 | 2008 | ||
| GAN BENG LEE | Director | 2 | 2008 | ||
| Chong Chin Cheong | Director | 2 | 2008 | ||
| NG TEE KHIANG | Director | 4 | 2009 | ||
| COLLINS MORTON | Director | 26 | 2009–2019 | ||
| Kim Jong Joseph | Director,Officer; Director,Officer,TenPercentOwner | Chief Executive Officer | 58 | 2009–2022 | |
| Rassas Kevin | Officer | Sr. VP Business Development | 4 | 2009 | |
| Sardesai Niranjan | Officer | Chief Operating Officer; Sr. VP Research & Development | 21 | 2009–2018 | |
| White Cheryl Jo | Officer | Chief Medical Officer | 2 | 2009 | |
| Wells Keith H | Director | 4 | 2009–2011 | ||
| Williams David J | Director | 3 | 2009–2010 | ||
| MARXE AUSTIN W & GREENHOUSE DAVID M | TenPercentOwner | 35 | 2011–2012 | ||
| Bagarazzi Mark | Officer | Chief Medical Officer | 14 | 2012–2019 | |
| MAHMOUD ADEL | Director | 9 | 2012–2018 | ||
| Cabrera Angel | Director | 15 | 2012–2020 | ||
| Wysenski Nancy | Director | 5 | 2015–2016 | ||
| Weiner David B. | Director | 41 | 2016–2026 | person page Fuzzy | |
| Bickerstaff George | Director | 4 | 2017–2018 | ||
| YARNO WENDY L | Director | 17 | 2017–2026 | ||
| Zoth Lota S. | Director | 16 | 2019–2026 | ||
| Humeau Laurent | Officer | Chief Scientific Officer | 30 | 2019–2026 | |
| Miller Ann Calby | Director | 15 | 2019–2026 | ||
| Shea Jacqueline Elizabeth | Director,Officer; Officer | Chief Executive Officer; Chief Operating Officer | 29 | 2019–2026 | |
| Shepard Jay | Director | 13 | 2020–2026 | ||
| DANSEY ROGER D | Director | 9 | 2021–2026 | ||
| Sumner Michael John | Officer | Chief Medical Officer | 18 | 2022–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2020-01-24 | INOVIO PHARMACEUTICALS, INC. | Biotechnology | $4,040,590 | $4,040,590 | 1 | 1 |
| 2019-08-15 | INOVIO PHARMACEUTICALS, INC. | Biotechnology | $15,164,526 | $15,164,526 | 14 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Inovio Pharmaceuticals, Inc. | PA | State business registries | name and state |
| Business registration | Inovio Pharmaceuticals, Inc. | PA | State business registries | name and state |
| Business registration | INOVIO PHARMACEUTICALS, INC | PA | State business registries | name and state |
| Business registration | INOVIO PHARMACEUTICALS, INC. | PA | State business registries | name and state |
| Form D issuer | INOVIO PHARMACEUTICALS, INC. | PA | Form D private offerings | CIK (EXACT) |
| Lobbying client | INOVIO PHARMACEUTICALS | PA | Federal lobbying (LDA) | name and state |
| Lobbying client | INOVIO PHARMACEUTICALS | PA | Federal lobbying (LDA) | name and state |
| Lobbying client | INOVIO PHARMACEUTICALS, INC. | PA | Federal lobbying (LDA) | name and state |
| Lobbying client | INOVIO PHARMACEUTICALS, INC. | PA | Federal lobbying (LDA) | name and state |
| Lobbying registrant | INOVIO PHARMACEUTICALS, INC. | PA | Federal lobbying (LDA) | name and state |
| Patent assignee | Inovio Pharmaceuticals, Inc. | PA | Patents (USPTO) | name and state |
| SEC filer | INOVIO PHARMACEUTICALS, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Inovio Pharmaceuticals, Inc. | PA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | INOVIO | EIN (EXACT) | ||
| Person page | David B Weiner | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, PA first:
- COLLAGENEX PHARMACEUTICALS INC PA
- ORAPHARMA INC PA
- VICURON PHARMACEUTICALS INC PA
- ADOLOR CORP PA
- PROTARGA INC PA
- Traws Pharma, Inc. PA
- MADRIGAL PHARMACEUTICALS, INC. PA
- Vitae Pharmaceuticals, Inc PA
- PhaseBio Pharmaceuticals Inc PA
- NeuBase Therapeutics, Inc. PA
In other datasets, the same topic (Health) in PA:
- Nonprofit: 445 FOUNDATION (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health